BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19075510)

  • 1. Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters.
    Morimoto E; Kanai Y; Kim DK; Chairoungdua A; Choi HW; Wempe MF; Anzai N; Endou H
    J Pharmacol Sci; 2008 Dec; 108(4):505-16. PubMed ID: 19075510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
    Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
    J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).
    Yamamoto A; Akanuma S; Tachikawa M; Hosoya K
    J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
    Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
    Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
    Yanagida O; Kanai Y; Chairoungdua A; Kim DK; Segawa H; Nii T; Cha SH; Matsuo H; Fukushima J; Fukasawa Y; Tani Y; Taketani Y; Uchino H; Kim JY; Inatomi J; Okayasu I; Miyamoto K; Takeda E; Goya T; Endou H
    Biochim Biophys Acta; 2001 Oct; 1514(2):291-302. PubMed ID: 11557028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
    Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
    J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
    Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
    Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.
    Simmons-Willis TA; Koh AS; Clarkson TW; Ballatori N
    Biochem J; 2002 Oct; 367(Pt 1):239-46. PubMed ID: 12117417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform selectivity of 3-125I-iodo-alpha-methyl-L-tyrosine membrane transport in human L-type amino acid transporters.
    Shikano N; Kanai Y; Kawai K; Inatomi J; Kim DK; Ishikawa N; Endou H
    J Nucl Med; 2003 Feb; 44(2):244-6. PubMed ID: 12571216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
    Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule.
    Park SY; Kim JK; Kim IJ; Choi BK; Jung KY; Lee S; Park KJ; Chairoungdua A; Kanai Y; Endou H; Kim DK
    Arch Pharm Res; 2005 Apr; 28(4):421-32. PubMed ID: 15918515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
    Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
    J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.
    Li S; Whorton AR
    J Biol Chem; 2005 May; 280(20):20102-10. PubMed ID: 15769744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.
    del Amo EM; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2008 Oct; 35(3):161-74. PubMed ID: 18656534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan.
    Kühne A; Kaiser R; Schirmer M; Heider U; Muhlke S; Niere W; Overbeck T; Hohloch K; Trümper L; Sezer O; Brockmöller J
    Pharmacogenet Genomics; 2007 Jul; 17(7):505-17. PubMed ID: 17558306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
    Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
    Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
    Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of system L amino acid transporter subtypes in rat placenta and yolk sac.
    Owaydhah WH; Ashton N; Verrey F; Glazier JD
    Placenta; 2021 Jan; 103():188-198. PubMed ID: 33160252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.
    Uchino H; Kanai Y; Kim DK; Wempe MF; Chairoungdua A; Morimoto E; Anders MW; Endou H
    Mol Pharmacol; 2002 Apr; 61(4):729-37. PubMed ID: 11901210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells.
    Pinho MJ; Serrão MP; Gomes P; Hopfer U; Jose PA; Soares-da-Silva P
    Kidney Int; 2004 Jul; 66(1):216-26. PubMed ID: 15200428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.